Abstract
Congenital tumors are rare and intriguing, and they are challenging, diagnostically, scientifically, therapeutically, and sometimes ethically. For many years, since at least when Willis wrote a book on the subject, there has been study of The Borderline of Embryology and Pathology. Congenital tumors certainly fit this space and this is reflected in their appearances and more in their molecular biology. They probably have a lot more to teach us.
There has not been the time for multiple mutations to develop as for adult tumors. These tumors are often genomically and chromosomally similar to the host, and morphologically they often appear to recapitulate differentiation. The genetic revolution has taken us further into understanding this close association, showing important pathways in cellular differentiation genes, imprinting, chromatin remodeling, and noncoding RNA. This may explain the issues related to whether these are tumors, or maldevelopment, or both sharing similar largely epigenetic pathways.
This chapter is a review of the major tumor types with some discussion of new entities and some of the pathogenetic factors. There are too many tumors and too many new discoveries to cover all the entities in detail, but this is to give a general guide to the topic.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Orbach D, Sarnacki S, Brisse HJ, Gauthier-Villars M, Jarreau PH, Tsatsaris V, et al. Neonatal cancer. Lancet Oncol. 2013;14:e609–20.
Isaacs Jr H. Tumors of the fetus and infant. An atlas. New York: Springer; 2002.
Choudhary K, Panda S, Beena VT, Rajeev R, Sivakumar R, Krishanan S. Sialoblastoma: a literature review from 1966–2011. Natl J Maxillofac Surg. 2013;4:13–8.
Solis-Coria A, Vargas-Gonzalez R, Sotelo-Avila C. Rhabdomyomatous mesenchymal hamartoma presenting as a skin tag in the sternoclavicular area. Pathol Oncol Res. 2007;13:375–8.
Alaggio R, Ninfo V, Rosolen A, Coffin CM. Primitive myxoid mesenchymal tumor of infancy: a clinicopathologic report of 6 cases. Am J Surg Pathol. 2006;30:388–94.
Klimstra DS, Wenig BM, Adair CF, Heffess CS. Pancreatoblastoma. A clinicopathologic study and review of the literature. Am J Surg Pathol. 1995;19:1371–89.
Isaacs HJ. Tumors of the fetus and newborn. Philadelphia: WB Saunders; 1997.
Campbell AN, Chan HS, O’Brien A, Smith CR, Becker LE. Malignant tumours in the neonate. Arch Dis Child. 1987;62:19–23.
Greaves M. In utero origins of childhood leukaemia. Early Hum Dev. 2005;81:123–9.
Kinsler VA, Birley J, Atherton DJ. Great Ormond Street Hospital for Children Registry for Congenital Melanocytic Naevi: prospective study 1988–2007. Part 1—epidemiology, phenotype and outcomes. Br J Dermatol. 2009;160:143–50.
Lambie M, Nadler C, Glat P, Van Duzer S, Halligan G, Geller E. Infantile melanoma–a triple threat: diagnosis and management. Ann Plast Surg. 2011;67:85–9.
Phadke PA, Rakheja D, Le LP, Selim MA, Kapur P, Davis A, et al. Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases. Am J Surg Pathol. 2011;35:656–69.
Moore SW, Satge D, Sasco AJ, Zimmermann A, Plaschkes J. The epidemiology of neonatal tumours. Report of an international working group. Pediatr Surg Int. 2003;19:509–19.
Werb P, Scurry J, Ostor A, Fortune D, Attwood H. Survey of congenital tumors in perinatal necropsies. Pathology. 1992;24:247–53.
Parkes SE, Muir KR, Southern L, Cameron AH, Darbyshire PJ, Stevens MC. Neonatal tumours: a thirty-year population-based study. Med Pediatr Oncol. 1994;22:309–17.
Bellacosa A. Developmental disease and cancer: biological and clinical overlaps. Am J Med Genet A. 2013;161A:2788–96.
Dome J HV. Wilms tumor overview. GeneReviews [serial on the Internet]. 2013. Available from: www.ncbi.nlm.nih.gov/books/NBK1294/.
Gamis AS, Smith FO. Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorder. Br J Haematol. 2012;159:277–87.
Isaacs Jr H. Fetal and neonatal leukemia. J Pediatr Hematol Oncol. 2003;25:348–61.
Rump P, Zeegers MP, van Essen AJ. Tumor risk in Beckwith-Wiedemann syndrome: a review and meta-analysis. Am J Med Genet A. 2005;136:95–104.
Botto LD, Flood T, Little J, Fluchel MN, Krikov S, Feldkamp ML, et al. Cancer risk in children and adolescents with birth defects: a population-based cohort study. PLoS One. 2013;8:e69077.
Merks JH, Ozgen HM, Koster J, Zwinderman AH, Caron HN, Hennekam RC. Prevalence and patterns of morphological abnormalities in patients with childhood cancer. JAMA. 2008;299:61–9.
Anonymous. Online Mendelian Inheritance in Man. Johns Hopkins University. 2015. Available from: http://www.omim.org/entry/194072.
Anonymous. Mosaic variegated aneuploidy syndrome 1; MVA1. Online Mendelian Inheritance in Man. Johns Hopkins University. 2015. Available from: http://www.omim.org/entry/257300.
Narod SA, Hawkins MM, Robertson CM, Stiller CA. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet. 1997;60:474–85.
Inskip PD, Harvey EB, Boice Jr JD, Stone BJ, Matanoski G, Flannery JT, et al. Incidence of childhood cancer in twins. Cancer Causes Control. 1991;2:315–24.
Bolande R. Prenatal exposures and childhood cancer. Pediatr Dev Pathol. 1999;2:208–14.
Arnon J, Meirow D, Lewis-Roness H, Ornoy A. Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum Reprod Update. 2001;7:394–403.
Einhorn L. Are there factors preventing cancer development during embryonic life? Oncodev Biol Med. 1983;4:219–29.
Gwyn K. Children exposed to chemotherapy in utero. J Natl Cancer Inst Monogr. 2005;34:69–71.
Berry C. Congenital malformations. In: Berry C, editor. Paediatric pathology. Berlin: Springer; 1996. p. 43–62.
Miller R. Environmental causes of cancer in childhood. Adv Pediatr. 1978;25:97–119.
Perera F. Molecular epidemiology: on the path to prevention? J Natl Cancer Inst Monogr. 2000;92:602–12.
Bove KE, Bhathena D, Wyatt RJ, Lucas BA, Holland NH. Diffuse metanephric adenoma after in utero aspirin intoxication. A unique case of progressive renal failure. Arch Pathol Lab Med. 1979;103:187–90.
Tuman KJ, Chilcote R, Berkow RI, Moohr JW. Mesothelioma in child with prenatal exposure to isoniazid. Lancet. 1980;2:362.
Allen Jr RW, Ogden B, Bentley FL, Jung AL. Fetal hydantoin syndrome, neuroblastoma, and hemorrhagic disease in a neonate. JAMA. 1980;244:1464–5.
Baptista T, Araujo H, Rada P, Hernandez L. Congenital neuroblastoma in a boy born to a woman with bipolar disorder treated with carbamazepine during pregnancy. Prog Neuropsychopharmacol Biol Psychiatry. 1998;22:445–54.
Buckley J. The aetiology of cancer in the very young. Br J Cancer. 1992;66:S8–12.
Borkhardt A, Wilda M, Fuchs U, Gortner L, Reiss I. Congenital leukaemia after heavy abuse of permethrin during pregnancy. Arch Dis Child Fetal Neonatal Ed. 2003;88:F436–7.
Slater ME, Linabery AM, Spector LG, Johnson KJ, Hilden JM, Heerema NA, et al. Maternal exposure to household chemicals and risk of infant leukemia: a report from the children’s oncology group. Cancer Causes Control. 2011;22:1197–204.
Harvey EB, Boice JJ, Honeyman M, Flannery JT. Prenatal x-ray exposure and childhood cancer in twins. N Engl J Med. 1985;312:541–5.
Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol. 1997;70:130–9.
Williams E. Radiation-induced thyroid cancer. Histopathology. 1993;23:387–9.
Bounacer A, Wicker R, Caillou B, et al. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene. 1997;15:1263–73.
Draper G, Vincent T, Kroll ME, Swanson J. Childhood cancer in relation to distance from high voltage power lines in England and Wales: a case-control study. Br Med J. 2005;330:1290.
Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer. 2006;6:193–203.
Shiota K, Yamada S. Assisted reproductive technologies and birth defects. Congenit Anom (Kyoto). 2005;45:39–43.
Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod. 2001;16:972–8.
Thompson JR, Gerald P, Willoughby ML, Armstrong BK. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet. 2001;358:1935–40.
Knudson AJ. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68:820–3.
Knudson Jr AG, Meadows A. Developmental genetics of neuroblastoma. J Natl Cancer Inst. 1976;57:675–82.
Knudson Jr AG, Strong L. Mutation and cancer: a model for Wilms’ tumor of the kidney. J Natl Cancer Inst. 1972;48:313–24.
Lee RS, Stewart C, Carter SL, Ambrogio L, Cibulskis K, Sougnez C, et al. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J Clin Invest. 2012;122:2983–8.
Grosfeld JL, Ballantine T, Lowe D, Baehner RL. Benign and malignant teratomas in children: analysis of 85 patients. Surgery. 1976;80:297–305.
Marsden HB, Birch J, Swindell R. Germ cell tumours of childhood: a review of 137 cases. J Clin Pathol. 1981;34:879–83.
Tapper D, Lack E. Teratomas in infancy and childhood. A 54-year experience at the Children’s Hospital Medical Center. Ann Surg. 1983;198:398–410.
Lack E. Extragonadal germ cell tumors of the head and neck region: review of 16 cases. Hum Pathol. 1985;16:56–64.
Perlman EJ, Kretschmar C. Pediatric germ cell tumors. Cancer Treat Res. 1997;92:163–200.
Gonzalez-Crussi F. Extragonadal teratomas, Atlas of tumor pathology, vol. 2. Bethesda: Armed Forces Institute of Pathology; 1982. p. 50–76.
Mosbech CH, Rechnitzer C, Brok JS, Rajpert-De Meyts E, Hoei-Hansen CE. Recent advances in understanding the etiology and pathogenesis of pediatric germ cell tumors. J Pediatr Hematol Oncol. 2014;36:263–70.
Du Plessis JP, Winship W, Kirstein JD. Fetus in fetu and teratoma. A case report and review. S Afr Med J. 1974;48:2119–22.
Naudin ten Cate L, Vermeij-Keers C, Smit DA, Cohen-Overbeek TE, Gerssen-Schoorl KB, Dijkhuizen T. Intracranial teratoma with multiple fetuses: pre- and post-natal appearance. Hum Pathol. 1995;26:804–7.
Isaacs Jr H. Perinatal (fetal and neonatal) germ cell tumors. J Pediatr Surg. 2004;39:1003–13.
Noseworthy J, Lack E, Kozakewich HP, Vawter GF, Welch KJ. Sacrococcygeal germ cell tumors in childhood: an updated experience with 118 patients. J Pediatr Surg. 1981;16:358–64.
Bale PM. Sacrococcygeal developmental abnormalities and tumors in children. Perspect Pediatr Pathol. 1984;8:9–56.
Perlman E. Germ cell tumors. In: Stocker JT, Askin F, editors. Pathology of solid tumors in children. London: Chapman & Hall; 1998. p. 213–34.
Sebire NJ, Fowler D, Ramsay AD. Sacrococcygeal tumors in infancy and childhood; a retrospective histopathological review of 85 cases. Fetal Pediatr Pathol. 2004;23:295–303.
Lemire RJ, Beckwith JB. Pathogenesis of congenital tumors and malformations of the sacrococcygeal region. Teratology. 1982;25:201–13.
Anonymous. Currarino syndrome. Online Mendelian Inheritance in Man. Johns Hopkins University. 2015. Available from: http://www.omim.org/entry/176450.
Heerema-McKenney A, Harrison MR, Bratton B, Farrell J, Zaloudek C. Congenital teratoma: a clinicopathologic study of 22 fetal and neonatal tumors. Am J Surg Pathol. 2005;29:29–38.
Storr U, Rupprecht T, Bornemann A, et al. Congenital intracerebral teratoma: a rare differential diagnosis in newborn hydrocephalus. Pediatr Radiol. 1997;27:262–4.
Heerema-McKenney A, Bowen J, Hill DA, Suster S, Qualman SJ, Members of Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from pediatric and adult patients with extragonadal germ cell tumors. Arch Pathol Lab Med. 2011;135:630–9.
Graf JL, Housely H, Albanese CT, Adzick NS, Harrison MR. A surprising histological evolution of preterm sacrococcygeal teratoma. J Pediatr Surg. 1998;33:177–9.
Hawkins E, Issacs H, Cushing B, Rogers P. Occult malignancy in neonatal sacrococcygeal teratomas. A report from a combined pediatric oncology group and children’s cancer group study. Am J Pediatr Hematol Oncol. 1993;15:406–9.
Gilcrease MZ, Brandt M, Hawkins EP. Yolk sac tumor identified at autopsy after surgical excision of immature sacrococcygeal teratoma. J Pediatr Surg. 1995;30:875–7.
McKenney JK, Heerema-McKenney A, Rouse RV. Extragonadal germ cell tumors: a review with emphasis on pathologic features, clinical prognostic variables, and differential diagnostic considerations. Adv Anat Pathol. 2007;14:69–92.
Olivares-Pakzad BA, Tazelaar H, Dehner LP, Kasperbauer JL, Bite U. Oropharyngeal hairy polyp with meningothelial elements. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:462–8.
Baumann FR, Nerlich A. Metastasizing cervical teratoma of the fetus. Pediatr Pathol. 1993;13:21–7.
Dehner LP, Mills A, Talerman A, Billman GF, Krous HF, Platz CE. Germ cell neoplasms of head and neck soft tissues: a pathologic spectrum of teratomatous and endodermal sinus tumors. Hum Pathol. 1990;21:309–18.
Kharga B, Kumar V, Prabhu PS, Sundeep PT, John SK. Neonatal gastric teratoma: a rare entity. J Clin Diagn Res. 2014;8:185–6.
Jenderny J, Köster E, Borchers O, et al. Interphase cytogenetics on paraffin sections of paediatric extragonadal yolk sac tumours. Virchows Arch. 1996;428:53–7.
Sridhar S, Al-Moallem B, Kamal H, Terrile M, Stallings RL. New insights into the genetics of neuroblastoma. Mol Diagn Ther. 2013;17:63–9.
Wieberdink J. Metastasis in neonatal neuroblastoma. In: Pochedly C, editor. Neuroblastoma, clinical and biological manifestations. New York: Elsevier; 1982. p. 13–21.
Chen CP, Chen S, Chuang CY, et al. Clinical and perinatal sonographic features of congenital adrenal cystic neuroblastoma: a case report with review of the literature. Ultrasound Obstet Gynecol. 1997;10:68–73.
Kozakewich HP, Perez-Atayde A, Donovan MJ, et al. Cystic neuroblastoma: emphasis on gene expression, morphology, and pathogenesis. Pediatr Dev Pathol. 1998;1:17–28.
Huff D. Diffuse, multicentric neurogenic tumors in two macerated fetuses: a possible intrauterine form of neurofibromatosis. Pediatr Pathol. 1985;4:125–36.
Langlois NE, Gray E. Scatterbrain fetus. J Pathol. 1992;168:347–8.
Beckwith JB, Martin RF. Observations on the histopathology of neuroblastomas. J Pediatr Surg. 1968;3:106–10.
Shimada H, Chatten J, Newton Jr WA, Sachs N, Hamoudi AB, Chiba T, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst. 1984;73:405–16.
Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S, et al. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children’s Cancer Group. Cancer. 2001;92:2451–61.
Schonherr C, Ruuth K, Kamaraj S, Wang CL, Yang HL, Combaret V, et al. Anaplastic lymphoma kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells. Oncogene. 2012;31:5193–200.
Ambros IM, Brunner C, Abbasi R, Frech C, Ambros PF. Ultra-high density SNP array in neuroblastoma molecular diagnostics. Front Oncol. 2014;4:202.
Joshi VV. Peripheral neuroblastic tumors: pathologic classification based on recommendations of international neuroblastoma pathology committee (modification of Shimada classification). Pediatr Dev Pathol. 2000;3:184–99.
Stephenson SR, Cook B, Mease AD, Ruymann FB. The prognostic significance of age and pattern of metastases in stage IV-S neuroblastoma. Cancer. 1986;58:372–5.
Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med. 1995;1:249–55.
Kerbl R, Urban C, Lackner H, et al. Connatal localized neuroblastoma. The case to delay treatment. Cancer. 1996;77:1395–401.
Fritsch P, Kerbl R, Lackner H. Urban C “Wait and see” strategy in localized neuroblastoma in infants: an option not only for cases detected by mass screening. Pediatr Blood Cancer. 2004;43:679–82.
Craft AW, Parker L. Poor prognosis neuroblastoma: is screening the answer? Br J Cancer. 1992;18:S96–101.
Kawakami T, Monobe Y, Monforte H, et al. Pathology review of screening negative neuroblastomas: a report from the Quebec Neuroblastoma Screening Project. Cancer. 1998;83:575–81.
Brown P. Treatment of infant leukemias: challenge and promise. Hematol Am Soc Hematol Educ Program. 2013;2013:596–600.
Bresters D, Reus A, Veerman AJ, van Wering ER, van der Does-van den Berg A, Kaspers GJ. Congenital leukaemia: the Dutch experience and review of the literature. Br J Haematol. 2002;117:513–24.
Zipursky A. Transient leukaemia—a benign form of leukaemia in newborn infants with trisomy 21. Br J Haematol. 2003;120:930–8.
Silvio F, Carlo L, Elena B, Nicoletta B, Daniela F, Roberto M. Transient abnormal myelopoiesis in Noonan syndrome. J Pediatr Hematol Oncol. 2002;24:763–4.
Weitzman S, Jaffe R. Uncommon histiocytic disorders: the non-Langerhans cell histiocytoses. Pediatr Blood Cancer. 2005;45:256–64.
Black J, Coffin CM, Dehner LP. Fibrohistiocytic tumors and related neoplasms in children and adolescents. Pediatr Dev Pathol. 2012;15:181–210.
Isaacs Jr H. Fetal and neonatal histiocytoses. Pediatr Blood Cancer. 2006;47:123–9.
Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol. 1990;7:19–73.
Chan JK, Lamant L, Algar E, Delsol G, Tsang WY, Lee KC, et al. ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy. Blood. 2008;112:2965–8.
Minkov M, Prosch H, Steiner M, et al. Langerhans cell histiocytosis in neonates. Pediatr Blood Cancer. 2005;45:802–7.
Willman C. Detection of clonal histiocytes in Langerhans cell histiocytosis: biology and clinical significance. Br J Cancer. 1994;23:S29–33.
Sheils C, Dover G. Frequency of congenital anomalies in patients with histiocytosis x. Am J Hematol. 1989;31:91–5.
Egeler RM, Neglia J, Puccetti DM, Brennan CA, Nesbit ME. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer. 1993;71:865–73.
Feldman AL, Berthold F, Arceci RJ, et al. Clonal relationship between precursor t-lymphoblastic leukaemia/lymphoma and langerhans-cell histiocytosis. Lancet Oncol. 2005;6:435–7.
Risma K, Jordan MB. Hemophagocytic lymphohistiocytosis: updates and evolving concepts. Curr Opin Pediatr. 2012;24:9–15.
Sullivan KE, Delaat C, Douglas SD, Filipovich AH. Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatr Res. 1998;44:465–8.
Goransdotter Ericson K, Fadeel B, Nilsson-Ardnor S, et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet. 2001;68:590–7.
Feldmann J, Callebaut I, Raposo G, et al. Munc13–4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115:461–73.
Ishii E, Ueda I, Shirakawa R, et al. Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions. Blood. 2005;105:3442–8.
Henter J. Biology and treatment of familial hemophagocytic lymphohistiocytosis: importance of perforin in lymphocyte-mediated cytotoxicity and triggering of apoptosis. Med Pediatr Oncol. 2002;38:305–9.
Janka GE, Schneider E. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol. 2004;124:4–14.
Horne A, Janka G, Maarten Egeler R, et al. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol. 2005;129:622–30.
Zvulunov A, Barak Y, Metzker A. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World Stat Anal Arch Dermatol. 1995;131:904–8.
Janssen D, Harms D. Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the Kiel pediatric tumor registry. Am J Surg Pathol. 2005;29:21–8.
Dehner L. Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol. 2003;27:579–93.
Freyer DR, Kennedy R, Bostrom BC, Kohut G, Dehner LP. Juvenile xanthogranuloma: forms of systemic disease and their clinical implications. J Pediatr. 1996;129:227–37.
Kauffman SL, Stout A. Congenital mesenchymal tumors. Cancer. 1965;18:460–76.
Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC; 2013.
Bruder E, Alaggio R, Kozakewich HP, Jundt G, Dehner LP, Coffin CM. Vascular and perivascular lesions of skin and soft tissues in children and adolescents. Pediatr Dev Pathol. 2012;15:26–61.
Anonymous. Myofibromatosis, infantile, 1; IMF1. Online Mendelian Inheritance in Man. Johns Hopkins University. 2015. Available from: http://www.omim.org/entry/228550.
Jennings TA, Duray P, Collins FS, Sabetta J, Enzinger FM. Infantile myofibromatosis. Evidence for an autosomal-dominant disorder. Am J Surg Pathol. 1984;8:529–38.
Zand DJ, Huff D, Everman D, et al. Autosomal dominant inheritance of infantile myofibromatosis. Am J Med Genet A. 2004;126:261–6.
Oudijk L, den Bakker MA, Hop WC, Cohen M, Charles AK, Alaggio R, et al. Solitary, multifocal and generalized myofibromas: clinicopathological and immunohistochemical features of 114 cases. Histopathology. 2012;60:E1–11.
Coffin CM, Neilson KA, Ingels S, Frank-Gerszberg R, Dehner LP. Congenital generalized myofibromatosis: a disseminated angiocentric myofibromatosis. Pediatr Pathol Lab Med. 1995;15:571–87.
Wright C, Corbally M, Hayes R, McDermott MB. Multifocal infantile myofibromatosis and generalized fibromuscular dysplasia in a child: evidence for a common pathologic process? Pediatr Dev Pathol. 2004;7:385–930.
Dormans JP, Spiegel D, Meyer J, et al. Fibromatoses in childhood: the desmoid/fibromatosis complex. Med Pediatr Oncol. 2001;37:126–31.
Cates JM, Stricker TP, Sturgeon D, Coffin CM. Desmoid-type fibromatosis-associated Gardner fibromas: prevalence and impact on local recurrence. Cancer Lett. 2014;353:176–81.
Wang WL, Nero C, Pappo A, Lev D, Lazar AJ, Lopez-Terrada D. CTNNB1 genotyping and APC screening in pediatric desmoid tumors: a proposed algorithm. Pediatr Dev Pathol. 2012;15:361–7.
Cheng JC, Tang S, Chen TM. Sternocleidomastoid pseudotumor and congenital muscular torticollis in infants: a prospective study of 510 cases. J Pediatr. 1999;134:712–6.
Reye RD. Recurring digital fibrous tumors of childhood. Arch Pathol. 1965;80:228–31.
Purdy LJ, Colby T. Infantile digital fibromatosis occurring outside the digit. Am J Surg Pathol. 1984;8:787–90.
Viale G, Doglioni C, Iuzzolino P, et al. Infantile digital fibromatosis-like tumour (inclusion body fibromatosis) of adulthood: report of two cases with ultrastructural and immunocytochemical findings. Histopathology. 1988;12:415–24.
Pettinato G, Manivel J, d’Amore ES, Jaszcz W, Gorlin RJ. Melanotic neuroectodermal tumor of infancy. A reexamination of a histogenetic problem based on immunohistochemical, flow cytometric, and ultrastructural study of 10 cases. Am J Surg Pathol. 1991;15:233–45.
Sebire NJ, Ramsay A, Sheppard M, Malone M, Harding B, Risdon RA. Intravascular inflammatory myofibroblastic tumors in infancy. Pediatr Dev Pathol. 2002;5:400–4.
Harvell JD, Kilpatrick S, White WL. Histogenetic relations between giant cell fibroblastoma and dermatofibrosarcoma protuberans. CD34 staining showing the spectrum and a simulator. Am J Dermatopathol. 1998;20:339–45.
Terrier-Lacombe MJ, Guillou L, et al. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data–a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol. 2003;27:27–39.
Gu W, Ogose A, Kawashima H, et al. Congenital dermatofibrosarcoma protuberans with fibrosarcomatous and myxoid change. J Clin Pathol. 2005;58:984–6.
Chung EB, Enzinger F. Infantile fibrosarcoma. Cancer. 1976;38:729–39.
Knezevich SR, Garnett M, Pysher TJ, Beckwith JB, Grundy PE, Sorensen PH. ETV6–NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res. 1998;58:5046–8.
Knezevich SR, McFadden D, Tao W, Lim JF, Sorensen PH. A novel ETV6–NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet. 1998;18:184–7.
Rubin BP, Chen C, Morgan TW, et al. Congenital mesoblastic nephroma t(12;15) is associated with etv6–NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol. 1998;153:1451–8.
Neifeld JP, Berg J, Godwin D, Saizberg AM. A retrospective epidemiologic study of pediatric fibrosarcomas. J Pediatr Surg. 1978;13:735–9.
Nonaka D, Sun C. Congenital fibrosarcoma with metastasis in a fetus. Pediatr Dev Pathol. 2004;7:187–91.
Salloum E, Caillaud J, Flamant F, Landman J, Lemerle J. Poor prognosis infantile fibrosarcoma with pathologic features of malignant fibrous histiocytoma after local recurrence. Med Pediatr Oncol. 1990;18:295–8.
Dickey GE, Sotelo-Avila C. Fibrous hamartoma of infancy: current review. Pediatr Dev Pathol. 1999;2:236–43.
Saab ST, McClain CM, Coffin CM. Fibrous hamartoma of infancy: a clinicopathologic analysis of 60 cases. Am J Surg Pathol. 2014;38:394–401.
Sotelo-Avila C, Bale PM. Subdermal fibrous hamartoma of infancy: pathology of 40 cases and differential diagnosis. Pediatr Pathol. 1994;14:39–52.
Lakshminarayanan R, Konia T, Welborn J. Fibrous hamartoma of infancy: a case report with associated cytogenetic findings. Arch Pathol Lab Med. 2005;129:520–2.
Enzinger FM, Zhang R. Plexiform fibrohistiocytic tumor presenting in children and young adults. An analysis of 65 cases. Am J Surg Pathol. 1988;12:818–26.
Remstein ED, Arndt C, Nascimento AG. Plexiform fibrohistiocytic tumor: clinicopathologic analysis of 22 cases. Am J Surg Pathol. 1999;23:662–70.
Leclerc S, Hamel-Teillac D, Oger P, Brousse N, Fraitag S. Plexiform fibrohistiocytic tumor: three unusual cases occurring in infancy. J Cutan Pathol. 2005;32:572–6.
Fetsch JF, Miettinen M, Laskin WB, Michal M, Enzinger FM. A clinicopathologic study of 45 pediatric soft tissue tumors with an admixture of adipose tissue and fibroblastic elements, and a proposal for classification as lipofibromatosis. Am J Surg Pathol. 2000;24:1491–500.
Ortega-Monzo C, Molina-Gallardo I, Monteagudo-Castro C, et al. Precalcaneal congenital fibrolipomatous hamartoma: a report of four cases. Pediatr Dermatol. 2000;17:429–31.
Landing BH, Nadorra R. Infantile systemic hyalinosis: report of four cases of a disease, fatal in infancy, apparently different from juvenile systemic hyalinosis. Pediatr Pathol Lab Med. 1986;6:55–79.
Glover MT, Lake B, Atherton DJ. Infantile systemic hyalinosis: newly recognized disorder of collagen? Pediatrics. 1991;87:228–34.
Senzaki H, Kiyozuka Y, Uemura Y, Shikata N, Ueda S, Tsubura A. Juvenile hyaline fibromatosis: a report of two unrelated adult sibling cases and a literature review. Pathol Int. 1998;48:230–6.
Urbina F, Sazunic I, Murray G. Infantile systemic hyalinosis or juvenile hyaline fibromatosis? Pediatr Dermatol. 2004;21:154–9.
Isaacs Jr H. Fetal and neonatal rhabdoid tumor. J Pediatr Surg. 2010;45:619–26.
Brennan B, Stiller C, Bourdeaut F. Extracranial rhabdoid tumours: what we have learned so far and future directions. Lancet Oncol. 2013;14:e329–36.
Lobe TE, Wiener E, Hays DM, et al. Neonatal rhabdomyosarcoma: the IRS experience. J Pediatr Surg. 1994;29:1167–70.
Anderson JR, Barr FG, Hawkins DS, Parham DM, Skapek SX, Triche TJ. Fusion-negative alveolar rhabdomyosarcoma: modification of risk stratification is premature. J Clin Oncol. 2010;28:e587–8; author reply e589–90.
Parham DM, Alaggio R, Coffin CM. Myogenic tumors in children and adolescents. Pediatr Dev Pathol. 2012;15:211–38.
Lundgren L, Angervall L, Stenman G, Kindblom LG. Infantile rhabdomyofibrosarcoma: a high-grade sarcoma distinguishable from infantile fibrosarcoma and rhabdomyosarcoma. Hum Pathol. 1993;24:785–95.
Anonymous. ISSVA classification for vascular anomalies. International Society for the Study of Vascular Anomalies. 2015. Approved at the 20th ISSVA Workshop, Melbourne, April 2014. Available from: issva.org/classification.
Chen TS, Eichenfield LF, Friedlander SF. Infantile hemangiomas: an update on pathogenesis and therapy. Pediatrics. 2013;131:99–108.
Bakaris S, Karabiber H, Yuksel M, Parmaksiz G, Kiran H. Case of large placental chorioangioma associated with diffuse neonatal hemangiomatosis. Pediatr Dev Pathol. 2004;7:258–61.
Johnson RE, Scheithauer B, Dahlin DC. Melanotic neuroectodermal tumor of infancy. A review of seven cases. Cancer. 1983;52:661–6.
Coffin CM, Alaggio R. Adipose and myxoid tumors of childhood and adolescence. Pediatr Dev Pathol. 2012;15:239–54.
McDermott MB, Ponder T, Dehner LP. Nasal chondromesenchymal hamartoma: an upper respiratory tract analogue of the chest wall mesenchymal hamartoma. Am J Surg Pathol. 1998;22:425–33.
Qualman SJ, Bowen J, Amin MB, Srigley JR, Grundy PE, Perlman EJ. Protocol for the examination of specimens from patients with Wilms tumor (nephroblastoma) or other renal tumors of childhood. Arch Pathol Lab Med. 2003;127:1280–9.
Marsden HB, Newton Jr W. New look at mesoblastic nephroma. J Clin Pathol. 1986;39:508–13.
Vujanic GM, Sandstedt B, Dijoud F, Harms D, Delemarre JF. Nephrogenic rest associated with a mesoblastic nephroma—what does it tell us? Pediatr Pathol Lab Med. 1995;15:469–75.
Sutherland RW, Weiner J, Hicks MJ, Hawkins EP, Chintagumpala M. Congenital mesoblastic nephroma in a child with the Beckwith-Wiedemann syndrome. J Urol. 1997;158:1532–3.
Gormley TS, Skoog S, Jones RV, Maybee D. Cellular congenital mesoblastic nephroma: what are the options. J Urol. 1989;142:479–83.
Marsden HB, Lawler W. Primary renal tumours in the first year of life. A population based review. Virchows Arch A Pathol Anat Histopathol. 1983;399:1–9.
Ritchey ML, Azizkhan R, Beckwith JB, Hrabovsky EE, Haase GM. Neonatal wilms’ tumor. J Pediatr Surg. 1995;30:856–9.
Bove KE, McAdams A. The nephroblastomatosis complex and its relationship to Wilms’ tumor: a clinicopathologic treatise. Perspect Pediatr Pathol. 1976;3:185–223.
Machin G. Persistent renal blastema (nephroblastomatosis) as a frequent precursor of Wilms’ tumor; a pathological and clinical review. Part 2. Significance of nephroblastomatosis in the genesis of Wilms’ tumor. Am J Pediatr Hematol Oncol. 1980;2:253–61.
Beckwith JB, Kiviat NB, Bonadio JF. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms’ tumor. Pediatr Pathol Affiliate Int Paediatr Pathol Assoc. 1990;10:1–36.
Mirkin LD, Azzarelli B, Seo IS. Extrarenal Wilms’ tumor with cerebellar metastasis in a four-year-old girl with spina bifida. Am J Clin Pathol. 1990;93:805–9.
Kusafuka T, Miao J, Yoneda A, Kuroda S, Fukuzawa M. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor. Genes Chromosomes Cancer. 2004;40:133–9.
Tekautz TM, Fuller C, Blaney S, et al. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol. 2005;23:1491–9.
Jerkins GR, Callihan T. Ossifying renal tumor of infancy. J Urol. 1986;135:120–1.
Sotelo-Avila C, Beckwith J, Johnson JE. Ossifying renal tumor of infancy: a clinicopathologic study of nine cases. Pediatr Pathol Lab Med. 1995;15:745–62.
Kataoka Y, Shimada H, Sugimoto T, et al. Congenital sarcoma in the terminal ileum histologically resembling clear cell sarcoma of the kidney: a case report with an immunohistochemical study. Hum Pathol. 1993;24:1026–30.
Isaacs Jr H. Fetal and neonatal hepatic tumors. J Pediatr Surg. 2007;42:1797–803.
Thompson PA, Chintagumpala M. Renal and hepatic tumors in the neonatal period. Semin Fetal Neonatal Med. 2012;17:216–21.
Cross SS, Variend S. Combined hepatoblastoma and yolk sac tumor of the liver. Cancer. 1992;69:1323–6.
Kim SN, Chi J, Kim YW, et al. Neonatal choriocarcinoma of liver. Pediatr Pathol. 1993;13:723–30.
Weinberg AG, Finegold M. Primary hepatic tumors of childhood. Hum Pathol. 1983;14:512–37.
Greer ML, Danin J, Lamont AC. Glomerulocystic disease with hepatoblastoma in a neonate: a case report. Pediatr Radiol. 1998;28:703–5.
Ross JA, Gurney J. Hepatoblastoma incidence in the united states from 1973 to 1992. Med Pediatr Oncol. 1998;30:141–2.
Tanimura M, Matsui I, Abe J, et al. Increased risk of hepatoblastoma among immature children with a lower birth weight. Cancer Res. 1998;58:3032–5.
Lack EE, Neave C, Vawter GF. Hepatoblastoma. A clinical and pathologic study of 54 cases. Am J Surg Pathol. 1982;6:693–705.
Teraguchi M, Nogi S, Ikemoto Y, et al. Multiple hepatoblastomas associated with trisomy 18 in a 3-year-old girl. Pediatr Hematol Oncol. 1997;14:463–7.
Stocker JT, Ishak K. Mesenchymal hamartoma of the liver: report of 30 cases and review of the literature. Pediatr Pathol Lab Med. 1983;1:245–67.
Tovbin J, Segal M, Tavori I, Lotan G, Maymon R. Hepatic mesenchymal hamartoma: a pediatric tumor that may be diagnosed prenatally. Ultrasound Obstet Gynecol. 1997;10:63–5.
Lennington WJ, Gray GJ, Page DL. Mesenchymal hamartoma of liver. A regional ischemic lesion of a sequestered lobe. Am J Dis Child. 1993;147:193–6.
Kapur RP, Berry JE, Tsuchiya KD, Opheim KE. Activation of the chromosome 19q microRNA cluster in sporadic and androgenetic-biparental mosaicism-associated hepatic mesenchymal hamartoma. Pediatr Dev Pathol. 2014;17:75–84.
Lauwers GY, Grant L, Donnelly WH, et al. Hepatic undifferentiated (embryonal) sarcoma arising in a mesenchymal hamartoma. Am J Surg Pathol. 1997;21:1248–54.
Isaacs H. Fetal brain tumors: a review of 154 cases. Am J Perinatol. 2009;26:453–66.
Isaacs Jr H. II. Perinatal brain tumors: a review of 250 cases. Pediatr Neurol. 2002;27:333–42.
Isaacs Jr H. I. Perinatal brain tumors: a review of 250 cases. Pediatr Neurol. 2002;27:249–61.
Di Rocco C, Iannelli A, Ceddia A. Intracranial tumors of the first year of life. A cooperative survey of the 1986–1987 Education Committee of the ISPN. Childs Nerv Syst. 1991;7:150–3.
Di Rocco C, Ceddia A, Iannelli A. Intracranial tumours in the first year of life. A report on 51 cases. Acta Neurochir (Wien). 1993;123:14–24.
Buetow PC, Smirniotopoulos J, Done S. Congenital brain tumors: a review of 45 cases. Am J Roentgenol. 1990;155:587–93.
Raisanen JM, Davis R. Congenital brain tumors. Pathology (Phila). 1993;2:103–16.
de Kock L, Sabbaghian N, Plourde F, Srivastava A, Weber E, Bouron-Dal Soglio D, et al. Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations. Acta Neuropathol. 2014;128:111–22.
Zimmerman MA, Goumnerova L, Proctor M, et al. Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor. J Neurooncol. 2005;72:77–84.
De Munnynck K, Van Gool S, Van Calenbergh F, et al. Desmoplastic infantile ganglioglioma: a potentially malignant tumor? Am J Surg Pathol. 2002;26:1515–22.
Ross JH, Rybicki L, Kay R. Clinical behavior and a contemporary management algorithm for prepubertal testis tumors: a summary of the prepubertal testis tumor registry. J Urol. 2002;168:1675–8; discussion 1678–9.
Luisiri A, Vogler C, Steinhardt G, Silberstein M. Neonatal cystic testicular gonadoblastoma. Sonographic and pathologic findings. J Ultrasound Med. 1991;10:59–61.
Hong JR, Barber M, Scott CI, Guttenberg M, Wolfson PJ. 3–year-old phenotypic female with campomelic dysplasia and bilateral gonadoblastoma. J Pediatr Surg. 1995;30:1735–7.
Swerdlow AJ, English J, Qiao Z. The risk of melanoma in patients with congenital nevi: a cohort study. J Am Acad Dermatol. 1995;32:595–9.
Hale EK, Stein J, Ben-Porat L, et al. Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi—results from the NYU-LCMN registry. Br J Dermatol. 2005;152:512–7.
Ka VS, Dusza S, Halpern AC, Marghoob AA. The association between large congenital melanocytic naevi and cutaneous melanoma: preliminary findings from an internet-based registry of 379 patients. Melanoma Res. 2005;15:61–7.
Hill DA, Jarzembowski JA, Priest JR, Williams G, Schoettler P, Dehner LP. Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol. 2008;32:282–95.
Foulkes WD, Priest JR, Duchaine TF. DICER1: mutations, microRNAs and mechanisms. Nat Rev Cancer. 2014;14:662–72.
Dishop MK, McKay EM, Kreiger PA, Priest JR, Williams GM, Langston C, et al. Fetal lung interstitial tumor (FLIT): a proposed newly recognized lung tumor of infancy to be differentiated from cystic pleuropulmonary blastoma and other developmental pulmonary lesions. Am J Surg Pathol. 2010;34:1762–72.
Potter JF, Schoeneman M. Metastasis of maternal cancer to the placenta and fetus. Cancer. 1970;25:380–8.
Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol. 2003;183:1128–35.
Haas J. Pregnancy in association with a newly diagnosed cancer: a population-based epidemiologic assessment. Int J Cancer. 1984;34:229–35.
Ackerman J, Gilbert-Barness E. Malignancy metastatic to the products of conception: a case report with literature review. Pediatr Pathol Lab Med. 1997;17:577–86.
Fox H. Pathology of the placenta. 2nd ed. London: WB Saunders; 1997.
Benirschke K, Kaufmann P. Pathology of the human placenta. 4th ed. New York: Springer; 2000.
Baergen RN, Johnson D, Moore T, Benirschke K. Maternal melanoma metastatic to the placenta: a case report and review of the literature. Arch Pathol Lab Med. 1997;121:508–11.
Rothman LA, Cohen C, Astarloa J. Placental and fetal involvement by maternal malignancy: a report of rectal carcinoma and review of the literature. Am J Obstet Gynecol. 1973;116:1023–34.
Teksam M, McKinney A, Short J, Casey SO, Truwit CL. Intracranial metastasis via transplacental (vertical) transmission of maternal small cell lung cancer to fetus: CT and MRI findings. Acta Radiol. 2004;45:577–9.
Walker JW, Reinisch J, Monforte HL. Maternal pulmonary adenocarcinoma metastatic to the fetus: first recorded case report and literature review. Pediatr Pathol Mol Med. 2002;21:57–69.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing
About this chapter
Cite this chapter
Charles, A.K. (2015). Congenital Tumors. In: Khong, T.Y., Malcomson, R.D.G. (eds) Keeling’s Fetal and Neonatal Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-19207-9_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-19207-9_18
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19206-2
Online ISBN: 978-3-319-19207-9
eBook Packages: MedicineMedicine (R0)